Shuffle for fans
Chatbot

The Cannabis Investing Podcast

Business

On The Cannabis Investing Podcast, host Rena Sherbill provides actionable investment insight and the context with which to understand the burgeoning cannabis industry. Interviews with C-level executives, scientists, law and sector experts give you investment ideas to consider, help you thinkRead more

Popular episodes

Making The Case For Mid-Tier MSOs

Dec 1 • 01:26:59

Jon DeCourcey, formerly of Canaccord now with Viridian Capital Advisors, also publishes his analysis on Seeking Alpha. We discuss recent cannabis earnings and why he favors mid-tier multi-state operators (MSOs) over the Big 5. SAFE Banking expectations, how he sees valuations growing. Why retail investors should be excited for stalled cannabis legislation. Uplisting cataly...

Cannabis - A Sobering Perspective

Nov 28 • 58:53

Cannabis Stocks Are A Coiled Spring - Industry Update With Brady Cobb

Nov 23 • 54:33

Fantastically timely and edifying episode with industry expert Brady Cobb. We talk recent legislation; moving from optics to real reform. SAFE Banking, uplisting and what legislation will mean for cannabis investors. MSOs, ETFs new and old, future valuations, Florida and NY/NJ markets; selling to Cresco, focus on premium products....

IM Cannabis CEO Oren Shuster - Multi-Country Operator

Nov 10 • 28:27

I talked to Oren Shuster, CEO of IM Cannabis, this week in Tel Aviv at its CannaBIZ conference. We discuss the significant share price decline in the industry across the board; the significance of the Republican announcement in the US. Israel's unique market, comparisons to Michigan; Germany and Europe and the growth still to come....

Standardizing Cannabis Operating Procedure

Nov 3 • 50:46

Green Flower, founded by CEO Max Simon in 2014, is a training platform built for cannabis professionals. Ganjier is its cannabis sommelier certification program. The GF Institute is its newest effort, focused on cannabis workforce development - 30 leading companies including AYR Wellness and Cresco, are founding member brands. Developing standardized process to asses canna...

Cannabis: Enigma No More

Oct 27 • 46:42

As the industry develops, interesting to see how and where. Digital content + cannabis = The Cannigma. Co-Founder and COO Wassim Bahous and CEO Elana Goldberg joined the podcast to talk starting a cannabis publication during the pandemic, the mission to make science-backed information more accessible. Majority of content mostly useful to those living in legal markets; glob...

Jim Belushi's Mission From God; GrowGeneration Partnership

Oct 13 • 57:16

"You should never feel bad about feeling good." Jim Belushi, actor and founder of Belushi Farms, sums up his feelings about cannabis. He joins Jeremy Corrao, Vice President of Commercial Operations at GrowGeneration to discuss their recent partnership, plans for greenhouses and how to get yields up. Advocating for change, home grow market and GRWG's plans for growth. Getti...

Cannabis Extraction

Oct 6 • 01:11:30

Lincoln Johnson, Co-Founder, CEO + CTO of EnCann, returns to the podcast to catch us up on the extraction space ("we're going to see a big shift") and his journey since we talked previously back in 2019. A fantastic take on starting up a cannabis business, navigating the industry, and what Lincoln learned from a long (and ultimately successful) arbitration process. ...

InterCure: Internationally Profitable Cannabis

Sep 10 • 50:11

InterCure is the most profitable cannabis company outside North America and recently uplisted to the Nasdaq. Israel's former Prime Minister, Chairman Ehud Barak and CEO Alex Rabinovitch join Rena Sherbill to discuss Israel's cannabis landscape and what investors can expect going forward. Europe's gradual progress, building a strong brand with top international names. Upsid...

180 Life Sciences: Looking At Inflammation With Cannabis

Sep 8 • 01:02:27

180 Life Sciences' Prof. Sir Marc Feldmann, who co-founded the company with cannabis trailblazer Prof. Raphael Mechoulam, joins Rena with Dr. Jonathan Rothbard, Chief Science Officer. Focusing on pain and inflammation space. Aiming for FDA approval. Human clinical trials. Limitations of bioavailability in CBD; non-psychoactive synthetic CBD....

Check out similar podcasts

Capable Wealth Podcast : Financial Freedom in Fifteen Minutes Or Less
Capablewealth.com | Hosted By Jared Paul
The Summercast
Team Summertime
Ekot
Sveriges Radio
Song Vs. Song
Todd Nathanson
TwitterBlogCareersPress KitCommunity GuidelinesTerms of ServicePrivacy Policy
© 2021 Akora Labs, Inc.